| Literature DB >> 28526534 |
Dariusz Rokicki1, Magdalena Pajdowska2, Joanna Trubicka3, Meow-Keong Thong4, Elżbieta Ciara3, Dorota Piekutowska-Abramczuk3, Maciej Pronicki5, Roman Sikora6, Rijad Haidar7, Mariusz Ołtarzewski8, Ewa Jabłońska8, Premala Muthukumarasamy4, Pavai Sthaneswar9, Chin-Seng Gan4, Małgorzata Krajewska-Walasek3, Rosalba Carrozzo10, Daniela Verrigni10, Michela Semeraro11, Cristiano Rizzo11, Roberta Taurisano11, Bader Alhaddad12, Reka Kovacs-Nagy12, Tobias B Haack13, Carlo Dionisi-Vici11, Ewa Pronicka14, Saskia B Wortmann15.
Abstract
The urea cycle disorder carbamoyl phosphate synthetase I deficiency is an important differential diagnosis in the encephalopathic neonate. This intoxication type inborn error of metabolism often leads to neonatal death or severe and irreversible damage of the central nervous system, even despite appropriate treatment. Timely diagnosis is crucial, but can be difficult on routine metabolite level. Here, we report ten neonates from eight families (finally) diagnosed with CPS1 deficiency at three tertiary metabolic centres. In seven of them the laboratory findings were dominated by significantly elevated urinary 3-methylglutaconic acid levels which complicated the diagnostic process. Our findings are both important for the differential diagnosis of patients with urea cycle disorders and also broaden the differential diagnosis of hyperammonemia associated with 3-methylglutaconic aciduria, which was earlier only reported in TMEM70 and SERAC1 defect.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28526534 DOI: 10.1016/j.cca.2017.05.023
Source DB: PubMed Journal: Clin Chim Acta ISSN: 0009-8981 Impact factor: 3.786